Cover Story

SIPs in the Age of Volatility: Will investors stay the course?
Will investors stay the course or will this volatility lead to a long-term shift away from SIPs?

2025-04-13

Digital

SUBSCRIBE NOW

Goodlife

Explore the charm of Southern California beyond LA, Hollywood through these immersive experiences

Beyond LA and Hollywood, explore southern California through a series of immersive experiences.

Columns

‘Basket’ approach offers better risk-adjusted returns: Radhika Gupta, MD & CEO, Edelweiss Asset Management Ltd

Traditionally, in financial markets, investments in equities have been rewarding in the long term.

Deep Dive

Debt funds have come into vogue amidst the market volatility. Will they continue to see demand?

In recent years, FPIs have made a beeline for debt funds. will the funds continue to outperform once the current volatility ebbs?

All that’s glittering is gold ETFs. But is it safe to invest in them?

Gold ETFs attracted Rs 14,929 crore in the first 11 months of FY25, more than double the Rs 5,248 crore logged in the previous financial year. is it a safe option?

Despite recent rise, passive funds have a long way to go

The recent market dip has forced investors to think about low-risk investing.

Is it time to shift gears towards thematic funds?

There has been a shift in investors' sentiment away from sectoral and thematic funds. Is the change here to stay?

Best Advice

Cut the Noise: Sushil Suri, Chairman & MD, Morepen Laboratories Ltd

Morepen Laboratories is engaged in the business of developing and marketing active pharmaceutical ingredients.

Interview

Investing requires constructing a portfolio: Aashish Somaiyaa, CEO, WhiteOak Capital AMC

Aashish Somaiyaa, CEO, WhiteOak Capital AMC, on why investors should stagger their investments, rather than deploy aggressively.

Stick with large cap funds: Vetri Subramaniam of UTI AMC

Vetri Subramaniam, CIO, UTI AMC, on the stock market correction, the way ahead, and more.

Equity is not the only growth asset, says Swarup Anand Mohanty of Mirae Asset Investment Managers

Swarup Anand Mohanty, Vice Chairman & CEO of Mirae Asset Investment Managers, on why this is an ideal time to stay committed to funds chosen for long-term goals.

Equities hold an edge over gold: A Balasubramanian of Aditya Birla Sun Life AMC

A. Balasubramanian, MD & CEO, Aditya Birla Sun Life AMC Ltd, on navigating market volatility and long-term wealth creation.

Best approach is to continue SIPs: Value Research CEO Dhirendra Kumar

Dhirendra Kumar, CEO, Value Research, on why asset allocation should not be the primary concern of first-time investors.

There is a huge universe for hybrid funds: DP Singh of SBI MF

DP Singh, Deputy MD & Joint CEO, SBI Mutual Fund, on why mid-caps provide quality opportunities.

Rajeev Thakkar's advice for investors: Stay the course for 10,15,20 years

Rajeev Thakkar, CIO and Director at Parag Parikh Financial Advisory Services, on navigating the choppy markets.

Pockets of value are emerging, says Navneet Munot of HDFC AMC

Navneet Munot, MD and CEO of HDFC Asset Management Company, on why India's fundamentals will remain strong despite foreign institutional investors shifting focus to China.

FPIs have to live with current taxation: Sebi Chief Tuhin Kanta Pandey

Sebi Chairman Tuhin Kanta Pandey on developing trust, protecting retail investors, and building capital markets worthy of a developed India.

The Buzz

Allianz Exit a Pivotal Moment

The key question for the Indian insurance sector now is whether composite licences will drive consolidation or would 100% FDI attract new entrants

IKEA doubles down on a sustainability-first strategy as it expands into North India

With its latest foray into North India, IKEA is doubling down on a strategy that prioritises sustainability over speed

India Hiring Resilient for B-Schools, to that of US and other overseas B-schools

Things are not bleak for business school placements in India when compared to that of US and other overseas B-schools

Eli Lilly launches weight-loss drug Mounjaro in India at Rs 3,500 per 2.5mg dose

Eli Lilly has launched weight-loss drug Mounjaro in India, priced at Rs 3,500 per injection for a 2.5mg dose. Will high costs be a barrier to the reach?

Q4FY25 Earnings: India Inc eyes muted profit and revenue growth

All eyes are on India Inc’s Q4FY25 earnings. There are expectations of profit and revenue growth remaining muted

RBI scrutiny on IndusInd Bank: Buried in the Details

IndusInd Bank faces RBI scrutiny as leadership tensions, governance concerns, and potential penalties mount. With stricter regulations in play, its future-and broader banking oversight-hangs in balance

Editor's Note

The Systematic Churn in Savings

The SIP discontinuation-to-registration ratio rose to 122% in February 2025, the highest since April 2021.

COMPANIES

NEWS